<DOC>
	<DOCNO>NCT01929629</DOCNO>
	<brief_summary>The purpose study assess safety tolerability orally administer AZD0914 healthy adult subject .</brief_summary>
	<brief_title>A Study Assess Safety , Tolerability Pharmacokinetics AZD0914</brief_title>
	<detailed_description>A Phase I , Randomized , Placebo-controlled , Single-center Study Assess Safety , Tolerability , Pharmacokinetics AZD0914 After Single Oral Administration Assess Effect Food Healthy Adult Volunteers</detailed_description>
	<criteria>Healthy male female ( nonchildbearing potential ) subject age 18 to55 year ( inclusive ) . Have body mass index ( BMI ) 18.00 30.50 kg/m2 weigh least 50 kg 100 kg Male subject willing use barrier contraception , ie , condom , day dose administration least 3 month dose administration IP History important clinically significant disease disorder , opinion PI , may either put subject risk participation study , influence result subject 's ability participate study History presence gastrointestinal , hepatic renal disease condition know interfere absorption , distribution , metabolism , excretion drug Any clinically important illness , medical/surgical procedure , trauma within 4 week first administration IP judge PI History gastrointestinal ulcer disease , inflammatory bowel disease , indigestion symptom &gt; 3 time week , blood stool previous 6 month relate anal trauma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>Healthy Volunteers</keyword>
	<keyword>First Time Man</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>